Literature DB >> 12973110

Clinicopathologic features of graft rejection of the first human hand allograft.

Jean Kanitakis1, Denis Jullien, Palmina Petruzzo, Nadey Hakim, Alain Claudy, Jean-Pierre Revillard, Earl Owen, Jean-Michel Dubernard.   

Abstract

BACKGROUND: The first human hand allograft, performed in Lyon, France, on September 23, 1998, was removed during month 29 posttransplantation as the result of rejection because the patient did not comply with the immunosuppressive treatment.
METHODS: The patient was regularly examined from the day of transplantation to amputation. Biopsies were taken from the skin of the allograft and examined immunohistologically. After amputation, various tissue specimens obtained from the allograft (including skin, tendons, bone, muscles, and joints) were studied.
RESULTS: From month 15 onward, the allografted skin presented lichenoid papules that progressively spread and coalesced into diffuse erythematous-scaly lesions over the allografted hand. Histologically, these showed an aspect of chronic lichenoid cutaneous graft-versus-host disease. At the time of amputation, erosive and necrotic areas over the skin were present. Pathologic examination of the allograft showed that the most severe changes were found in the skin. Mild inflammation was found in muscles and tendons. Bones (including bone marrow) and joints were spared.
CONCLUSIONS: The skin is the main target of rejection in human hand allografts. Close clinicopathologic monitoring of the skin is the most reliable way to detect rejection in human composite tissue allografts.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12973110     DOI: 10.1097/01.TP.0000079458.81970.9A

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  26 in total

1.  Immune responses in transplantation: application to composite tissue allograft.

Authors:  Aleksandra Klimczak; Maria Siemionow
Journal:  Semin Plast Surg       Date:  2007-11       Impact factor: 2.314

Review 2.  The evolution of functional hand replacement: From iron prostheses to hand transplantation.

Authors:  Kevin J Zuo; Jaret L Olson
Journal:  Plast Surg (Oakv)       Date:  2014       Impact factor: 0.947

3.  Composite tissue allotransplantation of the face: Decision analysis model.

Authors:  Sabrina Cugno; Sheila Sprague; Eric Duku; Achilleas Thoma
Journal:  Can J Plast Surg       Date:  2007

Review 4.  Composite tissue transplantation: a rapidly advancing field.

Authors:  K V Ravindra; S Wu; L Bozulic; H Xu; W C Breidenbach; S T Ildstad
Journal:  Transplant Proc       Date:  2008-06       Impact factor: 1.066

Review 5.  Outcomes after hand and upper extremity transplantation.

Authors:  Jaimie T Shores; Veronika Malek; W P Andrew Lee; Gerald Brandacher
Journal:  J Mater Sci Mater Med       Date:  2017-03-30       Impact factor: 3.896

Review 6.  Facial and hand allotransplantation.

Authors:  Bohdan Pomahac; Ryan M Gobble; Stefan Schneeberger
Journal:  Cold Spring Harb Perspect Med       Date:  2014-03-01       Impact factor: 6.915

7.  Chronic rejection of human face allografts.

Authors:  Nicco Krezdorn; Christine G Lian; Michael Wells; Luccie Wo; Sotirios Tasigiorgos; Shuyun Xu; Thiago J Borges; Rayven M Frierson; Ewelina Stanek; Leonardo V Riella; Bohdan Pomahac; George F Murphy
Journal:  Am J Transplant       Date:  2018-11-10       Impact factor: 8.086

Review 8.  Key psychosocial challenges in vascularized composite allotransplantation.

Authors:  Martin Kumnig; Sheila G Jowsey-Gregoire
Journal:  World J Transplant       Date:  2016-03-24

Review 9.  Vascularized composite tissue allotransplantation--state of the art.

Authors:  J Rodrigo Diaz-Siso; Ericka M Bueno; Geoffroy C Sisk; Francisco M Marty; Bohdan Pomahac; Stefan G Tullius
Journal:  Clin Transplant       Date:  2013-04-14       Impact factor: 2.863

Review 10.  Science of composite tissue allotransplantation.

Authors:  Bruce Swearingen; Kadiyala Ravindra; Hong Xu; Shengli Wu; Warren C Breidenbach; Suzanne T Ildstad
Journal:  Transplantation       Date:  2008-09-15       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.